Skip to main content
Premium Trial:

Request an Annual Quote

The BioCommerce Week Index: May 12, 2005

BioCommerce Week’s Index to the
Diversified Molecular Biology Tools Companies
Company
Ticker
Current Price
(
May 10, 2005)
Last Price
(
May 3, 2005)
% Change
Agilent
A
21.86
21.18
3.21
Applied Biosystems
ABI
22.45
22.62
-0.75
BD
BDX
59.17
59.17
0.00
Beckman
BEC
66.38
67.04
-0.98
Bio-Rad
BIO
52.58
49.62
5.97
Bruker
BRKR
3.54
3.4
4.12
GE
GE
35.83
36.1
-0.75
Harvard Bio
HBIO
3.4
3.82
-10.99
Invitrogen
IVGN
76.52
75.2
1.76
Molecular Devices
MDCC
18.81
18.42
2.12
PerkinElmer
PKI
18.88
18.01
4.83
Sigma
SIAL
59.54
59.44
0.17
Stratagene
STGN
9.19
8.2
12.07
Thermo
TMO
26.15
25.41
2.91
Waters
WAT
40.03
39.83
0.50
Index Average
34.29
33.83
1.35

Stratagene Boasts Biggest Gain in This Week's BCW Index

Stratagene's shares rose 12 percent to $9.19 during the five-day period ending Tuesday, far outgaining any of the other 14 companies that comprise the BioCommerce Week Index, a basket of multiplatform molecular biology tools companies. The gains for the firm were steady during the tracking period and surrounded the release on Tuesday of its Q1 financial results, which showed a 27-percent increase in Q1 revenues and beat out analysts' consensus estimate for the quarter.

The biggest decline of the week belonged to Harvard Bioscience, whose shares dropped roughly 11 percent. The firm's stock dropped steadily over the three-day period following the release of its first-quarter results. Harvard Bio reported a 1-percent increase in first-quarter revenue, and executives of the firm called the results "disappointing" in a conference call (see article on HBIO in this week's issue).

Overall, the BCW Index gained 1.35 percent to close at $34.29 on Tuesday, up for the third week in a row. The Index outgained the Dow Jones Industrial Average, which rose .2 percent, but trailed the Nasdaq, which gained 1.5 percent. The Nasdaq Biotech Index posted a sharp 4.3 percent gain for the tracking period.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.